Syndax Pharmaceuticals Inc short interest in 2021
In 2021, Syndax Pharmaceuticals Inc's disclosed short interest ran from 13.15% of shares outstanding on 15 Jan 2021 to 6.81% on 31 Dec 2021, a change of -6.34 percentage points. The year's high was 17.90% on 15 Jul 2021 and its low 6.43% on 30 Nov 2021, averaging 13.22% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 23.90 days on 28 May 2021. Full history: Syndax Pharmaceuticals Inc.
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2021 in figures
- Start of year
- 13.15% (15 Jan 2021)
- End of year
- 6.81% (31 Dec 2021)
- Change
- -6.34 pp
- High
- 17.90% (15 Jul 2021)
- Low
- 6.43% (30 Nov 2021)
- Average
- 13.22%
- Highest days to cover
- 23.90 (28 May 2021)
- SEC filings marked
- 8
Every report in 2021
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2021 | 13.15% | 14.05 | |
| 29 Jan 2021 | 11.82% | 6.68 | |
| 12 Feb 2021 | 12.07% | 12.71 | |
| 26 Feb 2021 | 12.06% | 9.33 | |
| 15 Mar 2021 | 11.01% | 6.46 | results (8-K), 10-K filed |
| 31 Mar 2021 | 14.09% | 9.13 | |
| 15 Apr 2021 | 13.08% | 11.93 | |
| 30 Apr 2021 | 15.22% | 3.86 | |
| 14 May 2021 | 15.04% | 9.29 | 10-Q filed, results (8-K) |
| 28 May 2021 | 15.61% | 23.90 | |
| 15 Jun 2021 | 16.00% | 17.07 | |
| 30 Jun 2021 | 16.28% | 10.45 | |
| 15 Jul 2021 | 17.90% | 21.04 | |
| 30 Jul 2021 | 16.97% | 21.71 | |
| 13 Aug 2021 | 16.51% | 22.50 | 10-Q filed, results (8-K) |
| 31 Aug 2021 | 16.96% | 21.24 | |
| 15 Sep 2021 | 16.08% | 16.25 | |
| 30 Sep 2021 | 14.32% | 8.87 | |
| 15 Oct 2021 | 13.01% | 11.19 | |
| 29 Oct 2021 | 12.89% | 18.44 | |
| 15 Nov 2021 | 6.89% | 5.23 | 10-Q filed, results (8-K) |
| 30 Nov 2021 | 6.43% | 7.75 | |
| 15 Dec 2021 | 7.19% | 4.63 | |
| 31 Dec 2021 | 6.81% | 4.50 |
See also: Syndax Pharmaceuticals Inc's full history · most shorted US stocks of 2021 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.